ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 79 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,186,000 | +1.4% | 35,000 | -49.4% | 0.67% | -2.0% |
| Q4 2016 | $1,170,000 | +7.8% | 69,215 | +4.7% | 0.68% | -8.7% |
| Q3 2016 | $1,085,000 | +26.9% | 66,110 | +17.0% | 0.75% | +71.2% |
| Q2 2016 | $855,000 | +195.8% | 56,500 | +182.5% | 0.44% | +312.3% |
| Q1 2016 | $289,000 | -91.3% | 20,000 | -82.9% | 0.11% | -92.8% |
| Q4 2015 | $3,321,000 | +94.9% | 117,257 | +15.2% | 1.47% | +25.9% |
| Q3 2015 | $1,704,000 | – | 101,766 | – | 1.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 657,467 | $2,709,000 | 2.82% |
| Healthcare Value Capital, LLC | 100,000 | $412,000 | 1.36% |
| Opaleye Management Inc. | 1,487,800 | $6,130,000 | 1.20% |
| Worth Venture Partners, LLC | 225,106 | $927,000 | 0.76% |
| ARMISTICE CAPITAL, LLC | 2,742,000 | $11,297,000 | 0.41% |
| DELTEC ASSET MANAGEMENT LLC | 355,845 | $1,466,000 | 0.26% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 329,437 | $1,357,000 | 0.19% |
| Mosaic Family Wealth, LLC | 92,357 | $381,000 | 0.14% |
| EMERALD ADVISERS, LLC | 642,226 | $2,646,000 | 0.11% |
| DCF Advisers, LLC | 31,236 | $129,000 | 0.07% |